107 related articles for article (PubMed ID: 395078)
1. A portable, pre-programmable insulin infusion system in diabetes mellitus.
Kølendorf K; Bojsen J
Horm Metab Res Suppl; 1979; (8):191-3. PubMed ID: 395078
[TBL] [Abstract][Full Text] [Related]
2. Continuous intravenous insulin therapy with a miniaturized open-loop system.
Renner R; Hepp KD; Mehnert H; Franetzki M
Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
[TBL] [Abstract][Full Text] [Related]
3. Closed-loop system in evaluation of insulin infusion rates for an open-loop system.
Kølendorf K; Christiansen JS; Svendsen PA; Bojsen J
Horm Metab Res Suppl; 1979; (8):205-6. PubMed ID: 395082
[TBL] [Abstract][Full Text] [Related]
4. Preprogrammed insulin infusion with a portable pump system.
Irsigler K; Kritz H; Kaspar L; Brändle J; Koller W; Franetzki M
Horm Metab Res Suppl; 1979; (8):193-7. PubMed ID: 119699
[TBL] [Abstract][Full Text] [Related]
5. A portable infusion pump, programmable with 16 rates.
Bojsen J; Kølendorf K; Haslev F; Jørgensen K
Biotelem Patient Monit; 1978; 5(3):123-33. PubMed ID: 754819
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
Stavljenić A; Granić M; Topić B; Skrabalo Z
Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
[TBL] [Abstract][Full Text] [Related]
7. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
Christiansen JS; Svendsen PA; Deckert T
Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
[TBL] [Abstract][Full Text] [Related]
8. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen.
Irsigler K; Kritz H; Kaspar L; Brändle J; Franetzki M
Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system.
Pickup JC; Viberti GC; Keen H; Parsons JA; Alberti KG
Horm Metab Res Suppl; 1979; (8):202-4. PubMed ID: 395081
[TBL] [Abstract][Full Text] [Related]
10. Insulin infusion pumps in the treatment of diabetes.
Blackshear PJ
Med Instrum; 1982; 16(1):17-9. PubMed ID: 7038411
[TBL] [Abstract][Full Text] [Related]
11. [Improvement in the treatment of diabetes by means of a portable insulin-infusion apparatus. Preliminary results in 4 unstable juvenile diabetics].
Porr O; Morell B; Walter H; Sturzenegger J; Froesch ER
Schweiz Med Wochenschr; 1980 Nov; 110(47):1761-3. PubMed ID: 7006076
[TBL] [Abstract][Full Text] [Related]
12. Optimal blood sugar control in labile diabetics using a portable open-loop insulin infusion system with a flexible program.
Froesch ER; Blatter G; Morell B
Horm Metab Res Suppl; 1979; (8):198-201. PubMed ID: 395079
[TBL] [Abstract][Full Text] [Related]
13. The external artificial pancreas: an instrument to induce remissions in severe recent juvenile diabetes. Comparison with a preprogrammed insulin infusion system.
Mirouze J; Selam JL; Pham TC; Orsetti A
Horm Metab Res Suppl; 1979; (8):141-5. PubMed ID: 395071
[TBL] [Abstract][Full Text] [Related]
14. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.
Tamborlane WV; Sherwin RS; Genel M; Felig P
N Engl J Med; 1979 Mar; 300(11):573-8. PubMed ID: 763270
[TBL] [Abstract][Full Text] [Related]
15. Determination of 24-hour insulin infusion pattern by an artificial endocrine pancreas for intravenous insulin infusion with a miniature pump.
Kølendorf K; Christiansen JS; Bojsen J; Svendsen PA; Teglbjaerg LL
Horm Metab Res; 1981 May; 13(5):245-9. PubMed ID: 7021384
[TBL] [Abstract][Full Text] [Related]
16. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
17. Metabolic studies during normoglycaemic clamping of insulin-dependent diabetics using a glucose-controlled insulin infusion system.
Nattrass M; Alberti KG; Buckle AL; Cluett B; Jaspan JB; Noy GA; Stubbs WA; Walton R
Horm Metab Res Suppl; 1979; (8):86-92. PubMed ID: 395096
[TBL] [Abstract][Full Text] [Related]
18. Remission of insulin dependence induced by continuous subcutaneous insulin infusion (CSII) in type I, recent onset diabetics: role of beta cell recovery and lymphocyte subsets distribution.
Guastamacchia E; Nardelli GM; Di Paolo S; Lattanzi V; Ciampolillo A; Lacasella R; Montedoro P; Giorgino R
Diabete Metab; 1988; 14(2):138-9. PubMed ID: 3042488
[No Abstract] [Full Text] [Related]
19. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
[TBL] [Abstract][Full Text] [Related]
20. Developmental and application of insulin infusion profiles for therapy of type-I diabetics with portable insulin infusion systems.
Schulz G; Strack T; Beyer J; Krause U; Cordes U; Weber T; Nagel J; Beutelspacher F
Life Support Syst; 1984; 2(3):189-200. PubMed ID: 6503348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
